XML 20 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 15,043 $ 11,858
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 1,927 889
Depreciation, amortization and accretion, net 5,592 2,908
Life Insurance, Corporate or Bank Owned, Change in Value (384) 0
Stock-based compensation expense 268 264
Gains on investment securities, net (1,130) (231)
Gain on sales of other real property owned, net (5) (32)
Gain (Loss) on Disposition of Property Plant Equipment 653 0
Loss on write down of fixed assets 26 166
Gains on sale of loans held for sale, net (805) (586)
Increase in accrued interest receivable (347) (298)
Decrease in accrued interest payable (36) (29)
Origination of loans held for sale (57,199) (43,106)
Proceeds from sale of loans held for sale 55,388 44,304
Increase in other assets (2,713) (2,327)
Decrease in other liabilities (1,036) (1,500)
Net cash provided by operating activities 15,242 12,280
Cash flows from investing activities:    
Proceeds from maturities of certificates of deposit investments 13,618 0
Purchases of certificates of deposit investments 12,958 12,930
Proceeds from sales of securities available-for-sale 68,726 9,453
Purchases of securities held-to-maturity 55,500 10,000
Proceeds from maturities of securities available-for-sale 91,899 55,057
Purchases of securities available-for-sale (84,102) (168,820)
Purchases of securities held-to-maturity (71,557) (10,000)
Net increase in loans (84,432) (23,068)
Proceeds from Sale of Property, Plant, and Equipment 147 0
Purchases of premises and equipment (449) (1,380)
Proceeds from sales of other real property owned 488 113
Payments to Acquire Life Insurance Policies (25,000) 0
Cash Acquired from Acquisition 36,774 279,468
Net cash (used in) provided by investing activities (11,346) 137,893
Cash flows from financing activities:    
Net (decrease) increase in deposits (3,996) 6,136
Decrease in repurchase agreements (24,673) (17,167)
Proceeds from FHLB advances 20,000 5,000
Repayment of FHLB advances 5,000 5,000
Proceeds from short-term debt 7,000 2,000
Proceeds from long-term debt 15,000 0
Repayment of short-term debt 0 2,000
Proceeds from issuance of common stock 97 28,165
Common stock issuance costs (230) 0
Purchase of treasury stock 0 (1,041)
Dividends paid on preferred stock 1,286 1,001
Dividends paid on common stock 3,555 1,532
Net cash provided by financing activities 3,357 13,560
Increase in cash and cash equivalents 7,253 163,733
Cash and cash equivalents at beginning of period 115,784 51,730
Cash and cash equivalents at end of period 123,037 215,463
Cash paid during the period for:    
Interest 2,568 2,506
Income taxes 9,335 6,961
Supplemental disclosures of noncash investing and financing activities    
Loans Transferred to Other Real Estate Owned 115 167
Dividends reinvested in common stock 1,052 597
Net tax benefit related to option and deferred compensation plans 140 85
Supplemental disclosure of purchase of capital stock of First Clover Leaf    
Fair value of assets acquired 668,905 0
Cash paid 22,545 0
Common stock issued 65,926 0
Total consideration paid 88,471 0
Fair value of liabilities assumed $ 580,434 $ 0